SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950142-13-002122
Filing Date
2013-10-23
Accepted
2013-10-23 16:22:27
Documents
3
Group Members
AISLING CAPITAL II LPAISLING CAPITAL PARTNERS LLCAISLING CAPITAL PARTNERS LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 eh1301173_13da1-adma.htm SC 13D/A 241319
2 EXHIBIT 1 eh1301172_13d-ex1.htm EX-99.1 30036
3 EXHIBIT 2 eh1301172_13d-ex2.htm EX-99.2 24311
  Complete submission text file 0000950142-13-002122.txt   297337
Mailing Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Aisling Capital II LP (Filed by) CIK: 0001350778 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 65 COMMERCE WAY HACKENSACK NJ 07601
Business Address 65 COMMERCE WAY HACKENSACK NJ 07601 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 0212
Type: SC 13D/A | Act: 34 | File No.: 005-82025 | Film No.: 131165939
SIC: 2836 Biological Products, (No Diagnostic Substances)